← Back to Clinical Trials
Recruiting NCT06545370

NCT06545370 Nurse-led Education on Patients With Chronic Heart Failure and Their Informal Caregivers

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06545370
Status Recruiting
Phase
Sponsor Hellenic Mediterranean University
Condition Heart Failure
Study Type INTERVENTIONAL
Enrollment 280 participants
Start Date 2024-09-01
Primary Completion 2026-09-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Intervention 1 / Nurse-led patients' educationIntervention 2 / Nurse-led patients' & caregivers' education

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 280 participants in total. It began in 2024-09-01 with a primary completion date of 2026-09-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The current study intends to examine the influence of nurse-led education on patients with chronic heart failure and their caregivers, with the goal of optimizing care for both and improving patients\' clinical outcomes.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 18 years * Patients recently hospitalized due to the disease * Patients and caregivers who are literate in Greek * Patients and caregivers who provide written informed consent for their participation in the study * Patients diagnosed with heart failure for at least 6 months * Caregivers who have been involved in the care of the patients for at least 6 months * Patients taking medication according to the guidelines of the European Society of Cardiology Exclusion Criteria: * History of psychiatric disease, recent history of alcohol or/and drug abuse, dementia, and Alzheimer\'s disease (for patients and caregivers) * Absence of an informal caregiver according to their statement

Contact & Investigator

Central Contact

Konstantinos Giakoumidakis, Associate Professor

✉ kongiakoumidakis@hmu.gr

📞 00306973793489

Frequently Asked Questions

Who can join the NCT06545370 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06545370 currently recruiting?

Yes, NCT06545370 is actively recruiting participants. Contact the research team at kongiakoumidakis@hmu.gr for enrollment information.

Where is the NCT06545370 trial being conducted?

This trial is being conducted at Heraklion, Greece, Heraklion, Greece.

Who is sponsoring the NCT06545370 clinical trial?

NCT06545370 is sponsored by Hellenic Mediterranean University. The trial plans to enroll 280 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology